Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies
Rifabutin acts in synergy and is bactericidal with frontline Mycobacterium abscessus antibiotics clarithromycin and tigecycline, suggesting a potent treatment combination
Tags: AIDS, antibody, HIV, Mycobutin®, tuberculosis
BASi Method Number SAP.375
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
